This paper presents a simple protocol for the measurement and evaluation of the difficult physiognomy of the female breast and the application of the protocol in clinical practice. The protocol includes measurement of the breast and its landmarks and their relevant position from fixed skeletal points. Volume was measured with the Grossman-Roudner device. The protocol provides a useful tool in the accurate evaluation of patients preoperatively and in the assessment of surgical results. The protocol is compared with the two previously reported protocols. The paper presents the anthropomorphic measurements of 50 women with aesthetically perfect breasts utilizing this protocol. Aesthetically perfect was defined as a nonptotic breast in which no common aesthetic procedure would be considered appropriate (excluding augmentation) to enhance the breast's form. Results were compared with those reported in the two previous studies. The paper presents the clinical correlation obtained by statistical analysis of the results of the measurements of the 50 women. Although the results of the measurements indicate the range and variance in the aesthetically perfect breast, there still was a statistically significant correlation of some of the parameters of the breast and torso shape to breast volume. This correlation can be used preoperatively to predict desired breast shape and volume in breast augmentation, reduction, and reconstruction. Clinical application of the concepts proposed will lead to better surgical goal orientation and improve evaluation of surgical results. A formula for calculating appropriate breast size based on torso parameters is presented.

No abstract

It appears that high-dose aspirin increases survival of ischemic flap tissue irrespective of the presence of microvascular anastomosis and may be of clinical benefit in all flap surgery. The authors have indicated no significant interest with commercial supporters.

Clopidogrel, a new antiplatelet agent that irreversibly inhibits platelet aggregation, is widely used today. This prospective work was conducted to evaluate the safety of performing skin surgery on patients taking clopidogrel. Patients undergoing surgery for excision of skin or subcutaneous lesions under local anesthesia taking clopidogrel were the study group. The control group comprised 2073 historical patients who had undergone a similar procedure. Data collected included: age, sex, past medical history, medications, and late complications. Follow-up was done at 1 to 2 weeks and 3 to 6 months. There were 32 patients on clopidogrel, having 38 lesions removed. Of these, seven patients were on aspirin and clopidogrel combined. The groups taking clopidogrel, aspirin, and warfarin had significantly more males, were older, and had significantly more comorbid medical conditions. There was no significant difference in the incidence of any of the complications in any of the groups. This study shows that patients taking clopidogrel before skin surgery, though older and with more associated medical conditions, do not experience a greater rate of complications. We conclude that patients undergoing minor excisional cutaneous surgery should continue taking clopidogrel because there is no apparent risk for increased complications when good meticulous surgical techniques are used.